Form D · Pharmaceuticals
CURE PHARMACEUTICAL Corp
Oxnard, CA · CIK 0001554289
Offering snapshot reported Oct 31, 2016 · SEC filing
- Reported sold
- $6.03M Offering amount: $6.03M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 31, 2016 | Initial | $6,033,963 | No comparison | 42 | SEC filing |
| Oct 31, 2016 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Oct 31, 2016 | Initial | $323,212 | No comparison | 1 | SEC filing |
| Oct 31, 2016 | Amendment | $2,000,000 | $500,000vs Oct 28, 2016 | 1 | SEC filing |
| Oct 28, 2016 | Initial | $80,000 | No comparison | 1 | SEC filing |
| Oct 28, 2016 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Mar 25, 2013 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jul 18, 2012 | Initial | $958,568 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $253K
- Finders' fees
- $0
- Form D file number
- 021-273536
Convertible Promissory Note
In addition to the sales commission described above, the Company is required to issue warrants to purchase an aggregate of 141,142 shares of common stock of the Company at an exercise price of $1.00 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Colorado Financial Service Corp. | 104343 |
Source: Form D, filed Oct 31, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vic Branstetter | Director |
| Rob Davidson | Director, Executive |
| Robert Davidson | Director, Executive |
| Edward Maliski | Director |
| Ed Maliski | Director |
| Wayne Nasby | Director |
| Ian Sephton | Director |
| Jonathan Turman | Director, Executive |
| Mark Udell | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1620 Beacon Place
Oxnard, CA, 93033
Oxnard, CA, 93033